Specifically, inhibiting miR-383-5p promotes HCC cell growth, invasion, metastasis, and angiogenesis, while increasing miR-383-5p levels reduces the expression of a key angiogenic factor VEGFA, suggesting a suppressive role of miR-383-5p in HCC development. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.